Radiesse for the greater Dallas/Fort Worth (DFW) Area

Radiesse - SAFE and EFFECTIVE

Rigorous clinical testing published in peer-reviewed medical journals, along with independent physician studies, have proven that Radiesse dermal filler is safe, effective, and long-lasting.

Radiesse dermal filler is made from a biocompatible substance that’s identical to what’s naturally found in the body. There’s virtually no risk of allergic reaction, and there have been very few side effects reported in clinical trials and actual use. After injection, Radiesse dermal filler will not migrate to other parts of the body. Over time, the microspheres contained in Radiesse dermal filler degrade naturally into calcium and phosphate ions that are safely metabolized by the body’s own processes.

Radiesse dermal filler has received CE mark certification, two FDA approvals, and a number of FDA clearances. Thousands of doctors worldwide are well trained in the proper techniques and best practices for the administration of Radiesse dermal filler. To find out whether Radiesse dermal filler is suitable for your treatment plans, please contact a doctor in your area.

Featured Publications

Busso, M., and Applebaum, D. (2007). Hand augmentation with Radiesse (calcium hydroxylapatite). Dermatologic Therapy, 20, 315-317.

Graivier, M. H., Bass, L. S., Busso, M., Jasin, M. E., Narins, R. S., and Tzikas, T. L. (2007). Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: Consensus recommendations. Plastic and Reconstructive Surgery, (Suppl.), 1S-10S.

Jacovella, P. F., Peiretti, C. B., Cunille, D., Salzamendi, M., and Schechtel, S. A. (2006). Patient satisfaction and longevity of Radiesse (calcium hydroxylapatite) as a facial soft tissue filler in adult females and adult males. Plastic and Reconstructive Surgery, 118(3 Suppl.), 15S-21S, discussion 31S-33S.

Moers-Carpi, M. M., and Tufet, J. O. (2007). Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: A 12-month, multicenter, prospective, randomized, controlled, split-face trial. American Society for Dermatologic Surgery, 34, 1-6.

Moers-Carpi, M. M., Vogt, S., Santos, B. M., Planas, J., Vallve, S. R., and Howell, D. J. (2007). A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. American Society for Dermatologic Surgery, 33: S144-S151.

Moers-Carpi, M. M. (2007). Head to head competition: One physician conducts a multicenter study to test the durability of two dermal fillers. Healthy Aging, 3(4), 15-16.

Sadick, N. S., Katz, B. E., and Roy, D. (2007). A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. American Society for Dermatologic Surgery, 33:S122-S127.

Tzikas, T. L. (2006). Radiesse raises the bar in facial augmentation. Aesthetic Buyers Guide, September/October 2006.